However, despite the amplification of UFC1 in pancreatic adenocarcinoma and amplification of both UFC1 and UFL1 in diffuse large B-cell lymphoma, high percentage of UFL1 deletion and UFL1/UFM1 deletion was also detected in pancreatic adenocarcinoma and diffuse large B-cell lymphoma, respectively (Table 1). This evidence concerns the gene UFM1 and diffuse large B-cell lymphoma.